Yale’s Krystal begins term as president of neuropsychopharmacology group
Dr. John Krystal, the Robert L. McNeil Jr. Professor of Translational Research and chair of the Department of Psychiatry, was installed as president of the American College of Neuropsychopharmacology (ACNP) at its annual business meeting last week.
He will serve a year term at the ACNP, the nation’s premier professional society, studying the neurobiology and treatment of neuropsychiatric disorders.
Krystal is also chief of psychiatry at Yale-New Haven Hospital and director of the Clinical Neuroscience Division of the Department of Veterans Affairs National Center for Posttraumatic Stress Disorder (PTSD).
The Yale scientist is one of the world’s pioneers in the area of “translational neuroscience” — the effort to link concepts and approaches arising from basic brain research to the study of the neurobiology and treatment of psychiatric disorders. He has applied this strategy to develop and test new approaches for treating schizophrenia PTSD, alcoholism, and depression.
In addition to his other roles, he directs the National Institute on Alcohol Abuse and Alcoholism’s Center for the Translational Neuroscience of Alcoholism, and he is a member of the National Alcohol Advisory Council. He also edits Biological Psychiatry, a leading journal of psychiatric neuroscience and therapeutics.
He has won several scientific awards and is a member of the Institute of Medicine of the U.S. National Academies of Science.